PFU THERAPEUTICS LTD
Significant control: Helen Foster (25–50%), Keith Foster (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Pfu Therapeutics Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Pfu Therapeutics Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
PFU THERAPEUTICS LTD is an active private limited company (company number 14588101) incorporated on 12 January 2023, registered in Harrow. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 January 2025, showing net assets of −£17k, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 86% on the prior period (−£9,208).
By net assets it sits in the bottom quarter of 151 comparable companies in Greater London (median £200, upper quartile £53k).
Ownership and control
- Mrs Helen Foster
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Mr. Keith Foster
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 12 January 20233 yrs ago
- Next accounts due
- 31 October 2026in 5 days
- Confirmation statement due
- 26 January 2027in 92 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 January 2025 | −£17k | — | — | — | — | — | 0 |
| 31 January 2024 | −£9,208 | — | — | — | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets below zeroNet assets £-17,106 at 31 January 2025
- Net assets down 25% or more on the prior period-85.8% vs prior period
- Incorporated two to five years agoIncorporated 12 January 2023
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 92 days
- Next accounts duein 5 days
- Accounts period endNet liabilities £17k · micro accounts
- Accounts period endNet liabilities £9,208 · micro accounts
- Incorporated
Similar companies in Greater London
- GRAVITON BIOSCIENCE LIMITEDAddlestone · inc. Jan 2023
- NEUROLANE LTDOrpington · inc. Feb 2023
- RENAISSANCE PHARMA LTDSurrey · inc. Dec 2022
- RELIEF EXPERTS UK LTDSouthall · inc. Nov 2022
- SCIHERO LIMITEDWallington · inc. Mar 2023
- ARJAN P LIMITEDWoodford Green · inc. Mar 2023
All companies incorporated on 12 January 2023 · in Jan 2023.
Reminders for PFU THERAPEUTICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.